Nielsen Q. Fernandez Becker International Celiac Disease Symposium 2026

Abstracts this author is presenting:

• Preclinical and Phase 1 Clinical Studies of HB-2121, A Novel Transglutaminase 2 Inhibitor for Celiac Disease — Afternoon Tea & Poster Session 1